|
|
DSpace at MIT >
MIT Libraries >
MIT Theses >
Theses - Science, Technology, and Society >
Science, Technology and Society - Ph.D. / Sc.D. >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/1721.1/39579
|
| Title: | Medicating race : heart disease and durable preoccupations with difference |
| Authors: | Pollock, Anne, Ph. D. Massachusetts Institute of Technology |
| Advisor: | David S. Jones. |
| Department: | Massachusetts Institute of Technology. Program in Science, Technology and Society. |
| Other contributors: | Massachusetts Institute of Technology. Program in Science, Technology and Society. |
| Keywords: | Program in Science, Technology and Society. |
| Issue Date: | 2007 |
| Publisher: | Massachusetts Institute of Technology |
| Abstract: | This dissertation is an examination of intersections of race, pharmaceuticals, and heart disease over the course of the 20th century and today. Each of these parts has had a dynamic history, and when they are invoked together they provide a terrain for arguments about interventions in health and in justice in the present. An enduring aspect of discourses of heart disease over the past century has been articulating connections between characterizations of the modem American way of life and of heart disease. In that process, heart disease research and practice has participated in differentiating Americans, especially by race. This dissertation uses heart disease categories and the drugs prescribed for them as windows into racialized medicine. The chapters are organized in a way that is roughly chronological, beginning with the emergence of cardiology as a specialty just before World War II and the landmark longitudinal Framingham Heart Study that began shortly thereafter. A central chapter tracks the emergence and mobilization of African American hypertension as a disease category since the 1960s.
(cont.) Two final chapters attend to current racial invocations of two pharmaceuticals: thiazide and BiDil. Using methods from critical historiography of race, anthropology, and science studies, this thesis provides an account of race in medicine with interdisciplinary relevance. By attending to continuities and discontinuities over the period, this thesis illustrates that race in heart disease research and practice has been a durable preoccupation. Racialized medicine has used epistemologically eclectic notions of race, drawing variously on heterogeneous aspects that are both material and semiotic. This underlying ambiguity is central to the productivity of the recorded category of race. American practices of medicating race have also been mediating it, arbitrating and intervening on new and renewed articulations of inclusion and difference in democratic and racialized American ways of life. |
| Description: | Thesis (Ph. D. in History and Social Study of Science and Technology (HASTS))--Massachusetts Institute of Technology, Program in Science, Technology and Society, 2007.
Includes bibliographical references (p. 320-350). |
| URI: | http://hdl.handle.net/1721.1/39579 |
| Appears in Collections: | Science, Technology and Society - Ph.D. / Sc.D.
Science, Technology & Society - Ph.D. / Sc.D.
|
Files in This Item:
| File |
Description |
Size | Format |
|---|
| 174291505.pdf | Preview, non-printable (open to all) | 22348Kb | Adobe PDF | View/Open | | 174291505-MIT.pdf | Full printable version (MIT only) | 22348Kb | Adobe PDF | View/Open |
|
|  |
This item is protected by original copyright
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|
